新里程：公司将定位为“AI+场景”，依托公司庞大医疗、养老场景，推动科技产业布局

Group 1 - The core strategy of the company involves expanding its product pipeline in the pharmaceutical industry through "BD + independent research and development," while also focusing on merger and acquisition opportunities to inject new product resources and market channels into its pharmaceutical sector [1] - In the AI healthcare field, the company positions itself as "AI + scenarios," leveraging its extensive medical and elderly care scenarios to drive technological industry layout [1] - The company has fully integrated its hospitals with the DeepSeek platform, launching AI smart report interpretation and AI medical assistant applications, which enhance the efficiency of diagnosis and treatment processes [1] Group 2 - Recent performance indicates that for the first nine months of 2025, the company achieved a revenue of 2.256 billion yuan, a year-on-year decrease of 23.40%, and a net loss of 38 million yuan, with losses expanding by 167.83% year-on-year [2] - The company is accelerating its strategic layout in rehabilitation and elderly care robotics, while also exploring investment opportunities in upstream and downstream core technology enterprises [3] - The company primarily engages in the production and sales of pharmaceuticals, as well as hospital management and related businesses [3]